Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Retina Vitreous Associates Medical Group · Apellis Pharmaceuticals (United States) · +12 more institutions
Indexed incrossrefpubmed
Abstract
Design
Prospective, multicenter, randomized, sham-controlled phase 2 study.
Participants
Two hundred forty-six patients with GA.
Citation impact
505
total citations
- FWCI
- 38.57
- Percentile
- 100%
- References
- 49
Citations per year
Authors
21Topics & keywords
Topics
Keywords
- Geographic atrophy
- Medicine
- Macular degeneration
- Complement (music)
- Atrophy
- Ophthalmology
- Pathology
- Genetics
No related works found for this paper.